MedPath

The effect of 3% hypertonic saline and salbutamol in treatment of patients with acute bronchiolitis

Not Applicable
Conditions
Acute bronchiolitis.
Acute bronchiolitis
Registration Number
IRCT2015092214333N39
Lead Sponsor
Vice chancellor for research, Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

children under 2 years old; children with acute bronchiolitis.
Exclusion criteria: children with cystic fibrosis; bronchopulmonary dysplasia and those with heart disease; premature babies with GA=34; patients who had used steroids during the last 48 hours prior to admission; children with immunodeficiency.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chest auscultation in terms of wheezing. Timepoint: Beginning and end of study. Method of measurement: By a doctor.;Cough. Timepoint: Beginning and end of study. Method of measurement: By doctor and counting.;Respiratory rate. Timepoint: Beginning and end of study. Method of measurement: By doctor and counting.;Blood oxygen saturation. Timepoint: Beginning and end of study. Method of measurement: By pulse oximeter.;Lung retraction. Timepoint: Beginning and end of study. Method of measurement: Based on physician observation.;The temperature of patient. Timepoint: Beginning and end of study. Method of measurement: Thermometer device.;Overall health of Patient. Timepoint: Beginning and end of study. Method of measurement: Based on physician observation and patient interview.;The severity of bronchiolitis. Timepoint: Beginning and end of study. Method of measurement: Based on the observations and examined by a doctor.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath